CIRCULOGENE
Daniel was the CEO of KCG Holdings, a New York-based public company with offices in Europe and Asia. Created in 2013 through the merger of Knight Capital Group and GETCO LLC, KCG was a leading trader of equities, futures, government bonds and options around the world. Prior to KCG, Daniel was CEO of GETCO, a privately held, automated trading firm based in Chicago. Daniel’s past board memberships include NASDAQ and The Boston Options Exchange. Daniel holds a B.A. from Yale University and an M.B.A. from the University of Chicago.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
CIRCULOGENE
Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence.